Form D · Other
Medicine Man Technologies, Inc.
Denver, CO · CIK 0001622879
Offering snapshot reported May 5, 2023 · SEC filing
- Reported sold
- $16M Offering amount: $16M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 21, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 5, 2023 | Initial | $16,000,000 | No comparison | 1 | SEC filing |
| Apr 27, 2023 | Initial | $5,542,990 | No comparison | 1 | SEC filing |
| Feb 9, 2023 | Initial | $3,750,000 | No comparison | 3 | SEC filing |
| Mar 28, 2022 | Initial | $1,900,000 | No comparison | 2 | SEC filing |
| Feb 25, 2022 | Initial | $11,600,000 | No comparison | 6 | SEC filing |
| Dec 20, 2021 | Initial | $95,000,000 | No comparison | 31 | SEC filing |
| Aug 5, 2021 | Initial | $4,842,000 | No comparison | Not reported | SEC filing |
| Mar 17, 2021 | Amendment | $53,700,000 | $38,250,000vs Dec 31, 2020 | 13 | SEC filing |
| Dec 31, 2020 | Initial | $15,450,000 | No comparison | 2 | SEC filing |
| Jun 14, 2019 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Sep 12, 2017 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Oct 21, 2016 | Initial | $500,000 | No comparison | 4 | SEC filing |
| Apr 7, 2015 | Amendment | $270,000 | $60,000vs Oct 21, 2014 | 23 | SEC filing |
| Nov 17, 2014 | Amendment | $210,000 | $0vs Oct 21, 2014 | 21 | SEC filing |
| Oct 21, 2014 | Initial | $210,000 | No comparison | 21 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-481004
Source: Form D, filed May 5, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan Berger | Director |
| Jeffrey Cozad | Director |
| Robert De Gabrielle | Director |
| Paul Dickman | Director, Executive |
| Justin Dye | Director, Executive |
| Jeffrey Garwood | Director |
| Joshua Haupt | Executive |
| Charles Haupt | Director |
| Forrest Hoffmaster | Director |
| Nancy Huber | Executive |
| Christine Jones | Director |
| Nirup Krishnamurthy | Director, Executive |
| Paul Montalbano | Director |
| Pratap Mukharji | Director |
| Dan Pabon | Executive |
| Daniel Pabon | Executive |
| Joseph P. Puglise | Executive |
| Leonardo Riera | Director |
| Brett Roper | Director, Executive |
| Marc Rubin | Director |
| Brian Ruden | Director |
| Jonathan Sandberg | Executive |
| Bradley Stewart | Director |
| Brad Stewart | Director |
| James C. Toreson | Director |
| Salim Wahdan | Director |
| Wei Wang | Executive |
| Andrew Williams | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
4880 Havana St. Suite 201
Denver, CO, 80239
Denver, CO, 80239